Encapsulation of fibrinogen and thrombin with calcium carbonate for hemorrhage control

Henry T Peng; Musaab Siddiqui

doi:10.55092/bm20230004

Article

Open Access

Encapsulation of fibrinogen and thrombin with calcium carbonate for hemorrhage control

Henry T Peng¹^,∗Musaab Siddiqui²

¹ Defence Research and Development Canada, Toronto Research Centre, Toronto, Canada

² Department of Nanotechnology Engineering, University of Waterloo, Waterloo, Canada

* henry.peng@drdc-rddc.gc.ca

Volume
Volume 1 Issue 1, 2023
Citation
Peng HT, Siddiqui M. Encapsulation of fibrinogen and thrombin with calcium carbonate for hemorrhage control. Biofunct. Mater. 2023(1):0004, https://doi.org/10.55092/bm20230004.
DOI
10.55092/bm20230004
Copyright
Copyright2023 by the authors. Published by ELSP.

Abstract

Hemorrhage remains the major cause of death in combat and civilian trauma, although significant advances in hemostatic agents and blood products have enhanced damage control resuscitation and reduced mortality. Currently, few hemostats are available for cessation of non-compressible torso hemorrhage, e.g., intra-abdominal hemorrhage. To address this hard-to-solve problem, self-propelling hemostatic particles composed of coagulation factors e.g., fibrinogen, thrombin, CaCO3 and protonated tranexamic acid (TXA+) that can move against blood flow and promote clot formation have been developed. This paper describes the preparation and characterization of CaCO3-encapsulated fibrinogen/thrombin particles. The particles were prepared by interfacial reaction method using water-oil-water emulsion under different conditions that varied in the concentrations of the coagulation factor and ammonium carbonate solutions, amounts of surfactants, mixing speed, volume ratio between water and oil phases. The resulting CaCO3 encapsulated fibrinogen/thrombin particles were characterized via light microscopy for morphology, gel electrophoresis for presence of fibrinogen and thrombin, rotational thromboelastometry for hemostatic effects and reaction with TXA+ for self-propulsion test. It was found that CaCO3 particles had spherical structure with less than 10 µm in diameter, could encapsulate fibrinogen and thrombin, enhance blood coagulation, and generate bubbles for propulsion by reacting with TXA+. Moreover, when particles were combined with TXA+, a synergistic hemostatic effect was obtained. These hemostatic and self-propelling properties could be optimized via changes to preparation method and composition. Further studies in animal bleeding models are warranted.

Keywords

Calciumcarbonate; hemorrhage control; hemostatic particle; fibrinogen; self-propulsion; thrombin; tranexamicacid; trauma

Preview

view pdf

References

[1]Eastridge BJ, Mabry RL, Seguin P, Cantrell J, Tops T, Uribe P, Mallett O, Zubko T, Oetjen-Gerdes L, Rasmussen TE, et al. Death on the battlefield (2001–2011): Implications for the future of combat casualty care. J Trauma Acute Care Surg 2012, 73(6):S431-S437
[2]Mazuchowski EL, Kotwal RS, Janak JC, Howard JT, Harcke HT, Montgomery HR, Butler FK, Holcomb JB, Eastridge BJ, Gurney JM, et al. Mortality review of us special operations command battle-injured fatalities. J Trauma Acute Care Surg 2020, 88(5):686-695.
[3]U. S. Burden of Disease Collaborators. The state of us health, 1990-2010: Burden of diseases, injuries, and risk factors. JAMA 2013, 310(6):591-606.
[4]Gruen RL, Brohi K, Schreiber M, Balogh ZJ, Pitt V, Narayan M, Maier RV. Haemorrhage control in severely injured patients. The Lancet 2012, 380(9847):1099-1108.
[5]Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: An overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006, 60(Suppl 6):S3-S9.
[6]Webster S, Barnard EBG, Smith JE, Marsden MER, Wright C. Killed in action (kia): An analysis of military personnel who died of their injuries before reaching a definitive medical treatment facility in afghanistan (2004-2014). BMJ Military Health 2021, 167(2):84-88.
[7]van Oostendorp SE, Tan ECTH, Geeraedts LMG. Prehospital control of life-threatening truncal and junctional haemorrhage is the ultimate challenge in optimizing trauma care; a review of treatment options and their applicability in the civilian trauma setting. Scand. J. Trauma, Resusc. Emerg 2016, 24(1):1-13.
[8]Welch M, Barratt J, Peters A, Wright C. Systematic review of prehospital haemostatic dressings. BMJ Military Health 2020, 166(3):194-200.
[9]Jamal L, Saini A, Quencer K, Altun I, Albadawi H, Khurana A, Naidu S, Patel I, Alzubaidi S, Oklu R. Emerging approaches to pre-hospital hemorrhage control: A narrative review. Ann Transl Med 2021, 9(14):1192.
[10]Schauer S, April M, Naylor J, Fisher A, Cunningham C, Ryan K, Thomas K, Brillhart D, Fernandez J, Antonacci M. Quikclot® combat gauze® use by ground forces in afghanistan the prehospital trauma registry experience. J Spec Oper Med 2017, 17(2):101-106.
[11]Johnson D, Johnson M. The effects of quikclot combat gauze and celox rapid on hemorrhage control. Am. J. Emerg. Med. 2019, 14(1):17-23.
[12]Baylis JR, Chan KYT, Kastrup CJ. Halting hemorrhage with self-propelling particles and local drug delivery. Thromb. Res. 2016, 141, Suppl 2:36-39.
[13]Watters JM, Van PY, Hamilton GJ, Sambasivan C, Differding JA, Schreiber MA. Advanced hemostatic dressings are not superior to gauze for care under fire scenarios. J Trauma 2011, 70(6):1413-1418.
[14]Hong C, Olsen BD, Hammond PT. A review of treatments for non-compressible torso hemorrhage (NCTH) and internal bleeding. Biomaterials 2022, 283:121432.
[15]Wan Y, Han J, Cheng F, Wang X, Wang H, Song Q, He W. Green preparation of hierarchically structured hemostatic epoxy-amine sponge. Chem. Eng. J. 2020, 397:125445.
[16]Li N, Yang X, Liu W, Xi G, Wang M, Liang B, Ma Z, Feng Y, Chen H, Shi C. Tannic acid cross-linked polysaccharide-based multifunctional hemostatic microparticles for the regulation of rapid wound healing. Macromol. Biosci. 2018, 18(11):1800209.
[17]Li L, Du Y, Yin Z, Li L, Peng H, Zheng H, Yang A, Li H, Lv G. Preparation and the hemostatic property study of porous gelatin microspheres both in vitro and in vivo. Colloids Surf. B 2020, 187:110641.
[18]Baylis JR, Yeon JH, Thomson MH, Kazerooni A, Wang X, St. John AE, Lim EB, Chien D, Lee A, Zhang JQ, et al. Self-propelled particles that transport cargo through flowing blood and halt hemorrhage. Sci. Adv. 2015, 1(9):e1500379.
[19]Peng H, Walford D. Development of biomaterials for treating battlefield hemorrhage part 1: Self-propelling particles. Scientific Report DRDC-RDDC-2020-R135. Toronto, ON, Canada: Defence Research and Development Canada; 2020.
[20]Mailafiya MM, Abubakar K, Danmaigoro A, Chiroma SM, Rahim EB, Moklas MAM, Zakaria ZA. Cockle shell-derived calcium carbonate (aragonite) nanoparticles: A dynamite to nanomedicine. Appl Sci-Basel 2019, 9(14):2897.
[21]Niu YQ, Liu JH, Aymonier C, Fermani S, Kralj D, Falini G, Zhou CH. Calcium carbonate: Controlled synthesis, surface functionalization, and nanostructured materials. Chem Soc Rev 2022, 51(18):7883-7943.
[22]Fadia P, Tyagi S, Bhagat S, Nair A, Panchal P, Dave H, Dang S, Singh S. Calcium carbonate nano- and microparticles: Synthesis methods and biological applications. 3 Biotech 2021, 11(11):457.
[23]Lin Y-J, Huang C-C, Wan W-L, Chiang C-H, Chang Y, Sung H-W. Recent advances in CO2 bubble-generating carrier systems for localized controlled release. Biomaterials 2017, 133:154-164.
[24]Tan C, Dima C, Huang M, Assadpour E, Wang J, Sun B, Kharazmi MS, Jafari SM. Advanced CaCO3-derived delivery systems for bioactive compounds. Adv. Colloid Interface Sci. 2022, 309:102791.
[25]Li H, Zhang X, Lin X, Zhuang S, Wu Y, Liu Z, Rong J, Zhao J. CaCO3 nanoparticles pH-sensitively induce blood coagulation as a potential strategy for starving tumor therapy. J. Mater. Chem. B 2020, 8(6):1223-1234.
[26]He W, Huang X, Zhang J, Zhu Y, Liu Y, Liu B, Wang Q, Huang X, He D. CaCO3–chitosan composites granules for instant hemostasis and wound healing. Materials 2021, 14(12):3350.
[27]Baylis JR, St. John AE, Wang X, Lim EB, Statz ML, Chien D, Simonson E, Stern SA, Liggins RT, White NJ, et al. Self-propelled dressings containing thrombin and tranexamic acid improve short-term survival in a swine model of lethal junctional hemorrhage. Shock 2016, 46(3):123-128.
[28]Baylis JR, Lee MM, St. John AE, Wang X, Simonson E, Cau M, Kazerooni A, Gusti V, Statz ML, Yoon JSJ, et al. Topical tranexamic acid inhibits fibrinolysis more effectively when formulated with self-propelling particles. J Thromb Haemost 2019, 17(10):1645-1654.
[29]Cau MF, Ali-Mohamad N, Baylis JR, Zenova V, Khavari A, Peng N, McFadden A, Donnellan F, Owen DR, Schaeffer DF, et al. Percutaneous delivery of self-propelling hemostatic powder for managing non-compressible abdominal hemorrhage: A proof-of-concept study in swine. Injury 2022, 53(5):1603-1609.
[30]Cau MF, Ali-Mohamad N, Yeh H, Baylis JR, Peng H, Gao HZ, Rezende-Neto J, Grecov D, White NJ, Tenn C, et al. Percutaneous delivery of self-propelling thrombin-containing powder increases survival from non-compressible truncal hemorrhage in a swine model of coagulopathy and hypothermia. J Trauma Acute Care Surg 2022, 93(2S Suppl 1):S86-S93.
[31]Aubron C, Reade MC, Fraser JF, Cooper DJ. Efficacy and safety of fibrinogen concentrate in trauma patients—a systematic review. J. Crit. Care 2014, 29(3):471.e411-e417.
[32]Kaushik JK, Bhat R. Why is trehalose an exceptional protein stabilizer?: An analysis of the thermal stability of proteins in the presence of the compatible osmolyte trehalose. J Biol Chem 2003, 278(29):26458-26465.
[33]Shi P, Zhou D, Zhu Y, Peng B, Shao N, Zan X. Thrombin-loaded TA-CaCO3 microspheres as a budget, adaptable, and highly efficient hemostatic. ACS Applied Bio Materials 2021, 4(1):1030-1037.
[34]Fujiwara M, Shiokawa K, Morigaki K, Zhu Y, Nakahara Y. Calcium carbonate microcapsules encapsulating biomacromolecules. Chem. Eng. J. 2008, 137(1):14-22.
[35]Arunagiri V, Tsai H-C, Darge HF, Chiang HW, Thankachan D, Mei C-J, Lai J-Y. Preparation of physically crosslinked polyelectrolyte gelatin-tannic acid-κ-carrageenan (GTC) microparticles as hemostatic agents. Int J Biol Macromol 2021, 191:324-334.
[36]Peng HT, Beckett A. Stability of reconstituted fibrinogen concentrate in hemostatic function and concentration. Mil Med 2020, 186(3-4):286-292.
[37]Lechner R, Helm M, Mueller M, Wille T, Friemert B. Efficacy of hemostatic agents in humans with rotational thromboelastometry: An in-vitro study. Mil Med 2016, 181(8):907-912.
[38]Chen J, Qiu L, Li Q, Ai J, Liu H, Chen Q. Rapid hemostasis accompanied by antibacterial action of calcium crosslinking tannic acid-coated mesoporous silica/silver janus nanoparticles. Materials Science & Engineering C, Materials for Biological Applications 2021, 123:111958.
[39]Schulz PM, Gehringer W, Nöhring S, Müller S, Schmidt T, Kekeiss-Schertler S, Solomon C, Pock K, Römisch J. Biochemical characterization, stability, and pathogen safety of a new fibrinogen concentrate (fibryga®). Biologicals 2018, 52(1):72-77.
[40]Buchta C, Dettke M, Funovics PT, Höcker P, Knöbl P, Macher M, Quehenberger P, Treitl C, Worel N. Fibrin sealant produced by the cryoseal® FS system: Product chemistry, material properties and possible preparation in the autologous preoperative setting. Vox Sang. 2004, 86(4):257-262.
[41]BioVision Inc. Thrombin, active, bovine plasma (technical grade) [cited 2022 August 1]. Available from: https://www.biovision.com/thrombin-active-bovine-plasma-technical-grade.html
[42]Medina-Sánchez M, Xu H, Schmidt OG. Micro- and nano-motors: The new generation of drug carriers. Ther. Deliv. 2018, 9(4):303-316.
[43]Peng H, Walford D. Development of biomaterials for treating battlefield hemorrhage part 2: Self-propelling particle-loaded gauzes. Scientific Report DRDC-RDDC-2022-R002. Toronto, ON, Canada; 2022.
[44]Fletcher DJ, Blackstock KJ, Epstein K, Brainard BM. Evaluation of tranexamic acid and ϵ-aminocaproic acid concentrations required to inhibit fibrinolysis in plasma of dogs and humans. Am. J. Vet. Res. 2014, 75(8):731-738.
[45]Rong J-j, Liang M, Xuan F-q, Sun J-y, Zhao L-j, Zhen H-z, Tian X-x, Liu D, Zhang Q-y, Peng C-f, et al. Alginate-calcium microsphere loaded with thrombin: A new composite biomaterial for hemostatic embolization. Int J Biol Macromol 2015, 75:479-488.
[46]Wang N, Zhao S, Tian X, Guang S, Xu H. Fabrication of microspheres containing coagulation factors by reverse microemulsion method for rapid hemostasis and wound healing. Colloids Surf. B 2022, 218:112742.
[47]Shi Z, Lan G, Hu E, Lu F, Qian P, Liu J, Dai F, Xie R. Puff pastry-like chitosan/konjac glucomannan matrix with thrombin-occupied microporous starch particles as a composite for hemostasis. Carbohydr. Polym. 2020, 232:115814.
[48]Shefa AA, Taz M, Lee SY, Lee B-T. Enhancement of hemostatic property of plant derived oxidized nanocellulose-silk fibroin based scaffolds by thrombin loading. Carbohydr. Polym. 2019, 208:168-179.
[49]Li G, Quan K, Xu C, Deng B, Wang X. Synergy in thrombin-graphene sponge for improved hemostatic efficacy and facile utilization. Colloids Surf. B 2018, 161(Supplement C):27-34.
[50]Baker SE, Sawvel AM, Fan J, Shi Q, Strandwitz N, Stucky GD. Blood clot initiation by mesocellular foams: Dependence on nanopore size and enzyme immobilization. Langmuir 2008, 24(24):14254-14260.
[51]Shi Y, Ding X, Cao Y, Zhou H, Yu W, Liu M, Yin J, Liu H, Wang J, Huang C, et al. Preparation and application of quick hemostatic gauze based on biomimetic mineralized thrombin. Biomater. Sci. 2021, 9(18):6098-6107.
[52]Spotnitz W. Fibrin sealant patches: Powerful and easy-to-use hemostats. Open Access Surg. 2014, 4:71-79.
[53]Jun J, Millican RC, Sherwood JA, Tucker BS, Vijayan VM, Alexander GC, Thomas V, Brott BC, Hwang PTJ. Evaluation of viscoelastic properties, blood coagulation, and cellular responses of a temperature-sensitive gel for hemostatic application. ACS Applied Bio Materials 2020, 3(5):3137-3144.
[54]Feoktistova NA, Vikulina AS, Balabushevich NG, Skirtach AG, Volodkin D. Bioactivity of catalase loaded into vaterite CaCO3 crystals via adsorption and co-synthesis. Mater. Des. 2020, 185:108223.
[55]Petrov AI, Volodkin DV, Sukhorukov GB. Protein—calcium carbonate coprecipitation: A tool for protein encapsulation. Biotechnol. Prog 2005, 21(3):918-925.
[56]Ergul Yilmaz Z, Cordonnier T, Debuigne A, Calvignac B, Jerome C, Boury F. Protein encapsulation and release from peo-b-polyphosphoester templated calcium carbonate particles. Int. J. Pharm. 2016, 513(1):130-137.
[57]Wu G-x, Ding J, Xue J. Synthesis of calcium carbonate capsules in water-in-oil-in-water double emulsions. J. Mater. Res. 2008, 23:140-149.
[58]Fujiwara M, Shiokawa K, Yotsuya K, Matsumoto K. Immobilization of lipase from burkholderia cepacia into calcium carbonate microcapsule and its use for enzymatic reactions in organic and aqueous media. J. Mol. Catal., B Enzym. 2014, 109:94-100.
[59]Fujiwara M, Shiokawa K, Araki M, Ashitaka N, Morigaki K, Kubota T, Nakahara Y. Encapsulation of proteins into CaCO3 by phase transition from vaterite to calcite. Cryst. Growth Des 2010, 10(9):4030-4037.
[60]Yang H, Wang Y, Liang T, Deng Y, Qi X, Jiang H, Wu Y, Gao H. Hierarchical porous calcium carbonate microspheres as drug delivery vector. Prog. Nat. Sci.: Mater 2017, 27(6):674-677.
[61]Peng H. Viscoelastic point-of-care tests for diagnosis of fibrinogen deficiency and guidance of fibrinogen administration in bleeding patients An ebook on biomedical sciences, 2021:1-61.
[62]Deng L, Qi Y, Liu Z, Xi Y, Xue W. Effect of tannic acid on blood components and functions. Colloids Surf. B 2019, 184:110505.
[63]Hong C, Alser O, Gebran A, He Y, Joo W, Kokoroskos N, Velmahos G, Olsen BD, Hammond PT. Modulating nanoparticle size to understand factors affecting hemostatic efficacy and maximize survival in a lethal inferior vena cava injury model. ACS Nano 2022, 16(2):2494-2510.
[64]Li Q, Hu E, Yu K, Xie R, Lu F, Lu B, Bao R, Zhao T, Dai F, Lan G. Self-propelling janus particles for hemostasis in perforating and irregular wounds with massive hemorrhage. Adv. Funct. Mater. 2020, 30(42):2004153.
[65]Volodkin DV, Larionova NI, Sukhorukov GB. Protein encapsulation via porous CaCO3 microparticles templating. Biomacromolecules 2004, 5(5):1962-1972.
[66]Song B, Yang L, Han L, Jia L. Metal ion-chelated tannic acid coating for hemostatic dressing. Materials 2019, 12(11):1803.
[67]Mackie IJ, Kitchen S, Machin SJ, Lowe GDO. Guidelines on fibrinogen assays. Br J Haematol 2003, 121(3):396-404.
[68]Mackie I, Lawrie A, Kitchen S, Gaffney P, Howarth D, Lowe G, Martin J, Purdy G, Rigsby P, Rumley A. A performance evaluation of commercial fibrinogen reference preparations and assays for clauss and pt-derived fibrinogen. Thromb. Haemost. 2002, 87(6):997-1005.
[69]Liu C, Shi Z, Zhu J, Liu C, Liu X, Khan NU, Liu S, Wang X, Wang X, Huang F. Armoring a liposome-integrated tissue factor with sacrificial CaCO3 to form potent self-propelled hemostats. J Mater Chem B 2023, 11(12):2778-2788.
[70]Lauth V, Maas M, Rezwan K. Coacervate-directed synthesis of CaCO3 microcarriers for pH-responsive delivery of biomolecules. J Mater Chem B 2014, 2(44):7725-7731.
[71]Bewernitz MA, Lovett AC, Gower LB. Liquid–solid core-shell microcapsules of calcium carbonate coated emulsions and liposomes. Appl. Sci. 2020, 10(23):8551.
[72]Shi P, Qin J, Hu J, Bai Y, Zan X. Insight into the mechanism and factors on encapsulating basic model protein, lysozyme, into heparin doped CaCO3. Colloids Surf. B 2019, 175:184-194.